These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 38612910)

  • 1. DKK3 Expression in Glioblastoma: Correlations with Biomolecular Markers.
    Caffo M; Casili G; Caruso G; Barresi V; Campolo M; Paterniti I; Minutoli L; Ius T; Esposito E
    Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DKK3 expression is associated with immunosuppression and poor prognosis in glioblastoma, in contrast to lower-grade gliomas.
    Han MH; Baek JM; Min KW; Cheong JH; Ryu JI; Won YD; Kwon MJ; Koh SH
    BMC Neurol; 2023 May; 23(1):183. PubMed ID: 37149563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High DKK3 expression related to immunosuppression was associated with poor prognosis in glioblastoma: machine learning approach.
    Han MH; Min KW; Noh YK; Kim JM; Cheong JH; Ryu JI; Won YD; Koh SH; Myung JK; Park JY; Kwon MJ
    Cancer Immunol Immunother; 2022 Dec; 71(12):3013-3027. PubMed ID: 35599254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DKK3 Overexpression Increases the Malignant Properties of Head and Neck Squamous Cell Carcinoma Cells.
    Katase N; Nishimatsu SI; Yamauchi A; Yamamura M; Terada K; Itadani M; Okada N; Hassan NMM; Nagatsuka H; Ikeda T; Nohno T; Fujita S
    Oncol Res; 2018 Jan; 26(1):45-58. PubMed ID: 28470144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DKK3 knockdown confers negative effects on the malignant potency of head and neck squamous cell carcinoma cells via the PI3K/Akt and MAPK signaling pathways.
    Katase N; Nishimatsu SI; Yamauchi A; Yamamura M; Fujita S
    Int J Oncol; 2019 Mar; 54(3):1021-1032. PubMed ID: 30569110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pax6 regulates the expression of Dkk3 in murine and human cell lines, and altered responses to Wnt signaling are shown in FlpIn-3T3 cells stably expressing either the Pax6 or the Pax6(5a) isoform.
    Forsdahl S; Kiselev Y; Hogseth R; Mjelle JE; Mikkola I
    PLoS One; 2014; 9(7):e102559. PubMed ID: 25029272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of the Wnt antagonist Dickkopf-3 is associated with prognostic clinicopathologic characteristics and impairs proliferation and invasion in endometrial cancer.
    Dellinger TH; Planutis K; Jandial DD; Eskander RN; Martinez ME; Zi X; Monk BJ; Holcombe RF
    Gynecol Oncol; 2012 Aug; 126(2):259-67. PubMed ID: 22555103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-95-3p promoted the development of prostatic cancer via regulating DKK3 and activating Wnt/β-catenin pathway.
    Xi M; Cheng L; Hua W; Zhou YL; Gao QL; Yang JX; Qi SY
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1002-1011. PubMed ID: 30779066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HCV Core protein represses DKK3 expression via epigenetic silencing and activates the Wnt/β-catenin signaling pathway during the progression of HCC.
    Wang X; Zhou Y; Wang C; Zhao Y; Cheng Y; Yu S; Li X; Zhang W; Zhang Y; Quan H
    Clin Transl Oncol; 2022 Oct; 24(10):1998-2009. PubMed ID: 35768685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blocking of the interaction between Wnt proteins and their co-receptors contributes to the anti-tumor effects of adenovirus-mediated DKK3 in glioblastoma.
    Hara K; Kageji T; Mizobuchi Y; Kitazato KT; Okazaki T; Fujihara T; Nakajima K; Mure H; Kuwayama K; Hara T; Nagahiro S
    Cancer Lett; 2015 Jan; 356(2 Pt B):496-505. PubMed ID: 25301448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DKK3 expression is correlated with poorer prognosis in head and neck squamous cell carcinoma: A bioinformatics study based on the TCGA database.
    Katase N; Nishimatsu SI; Yamauchi A; Okano S; Fujita S
    J Oral Biosci; 2023 Dec; 65(4):334-346. PubMed ID: 37716425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DKK3/CKAP4 axis is associated with advanced stage and poorer prognosis in oral cancer.
    Katase N; Kudo K; Ogawa K; Sakamoto Y; Nishimatsu SI; Yamauchi A; Fujita S
    Oral Dis; 2023 Nov; 29(8):3193-3204. PubMed ID: 35708905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monocentric evaluation of Ki-67 labeling index in combination with a modified RPA score as a prognostic factor for survival in IDH-wildtype glioblastoma patients treated with radiochemotherapy.
    Dumke R; Dumke C; Eberle F; Nimsky C; Keber U; Engenhart-Cabillic R; Lautenschläger S
    Strahlenther Onkol; 2022 Oct; 198(10):892-906. PubMed ID: 35612598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of two novel activities of the Wnt signaling regulator Dickkopf 3 and characterization of its expression in the mouse retina.
    Nakamura RE; Hunter DD; Yi H; Brunken WJ; Hackam AS
    BMC Cell Biol; 2007 Dec; 8():52. PubMed ID: 18093317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DKK3 blocked translocation of β-catenin/EMT induced by hypoxia and improved gemcitabine therapeutic effect in pancreatic cancer Bxpc-3 cell.
    Guo Q; Qin W
    J Cell Mol Med; 2015 Dec; 19(12):2832-41. PubMed ID: 26395974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dkk3 prevents familial dilated cardiomyopathy development through Wnt pathway.
    Lu D; Bao D; Dong W; Liu N; Zhang X; Gao S; Ge W; Gao X; Zhang L
    Lab Invest; 2016 Feb; 96(2):239-48. PubMed ID: 26641069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cantharidin inhibits osteosarcoma proliferation and metastasis by directly targeting miR-214-3p/DKK3 axis to inactivate β-catenin nuclear translocation and LEF1 translation.
    Hu S; Chang J; Ruan H; Zhi W; Wang X; Zhao F; Ma X; Sun X; Liang Q; Xu H; Wang Y; Yang Y
    Int J Biol Sci; 2021; 17(10):2504-2522. PubMed ID: 34326690
    [No Abstract]   [Full Text] [Related]  

  • 18. Prognostic relevance of Wnt-inhibitory factor-1 (WIF1) and Dickkopf-3 (DKK3) promoter methylation in human breast cancer.
    Veeck J; Wild PJ; Fuchs T; Schüffler PJ; Hartmann A; Knüchel R; Dahl E
    BMC Cancer; 2009 Jul; 9():217. PubMed ID: 19570204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DKK3 expression and function in head and neck squamous cell carcinoma and other cancers.
    Katase N; Nagano K; Fujita S
    J Oral Biosci; 2020 Mar; 62(1):9-15. PubMed ID: 32032750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MYCN is a novel oncogenic target in adult B-ALL that activates the Wnt/β-catenin pathway by suppressing DKK3.
    Kong D; Zhao L; Sun L; Fan S; Li H; Zhao Y; Guo Z; Lin L; Cui L; Wang K; Chen W; Zhang Y; Zhou J; Li Y
    J Cell Mol Med; 2018 Jul; 22(7):3627-3637. PubMed ID: 29673070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.